Charles Schwab Investment Management Inc Omeros Corp Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Omeros Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 485,035 shares of OMER stock, worth $4.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
485,035
Previous 466,581 3.96%
Holding current value
$4.18 Million
Previous $1.89 Million 1.64%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$3.54 - $5.47 $65,327 - $100,943
18,454 Added 3.96%
485,035 $1.93 Million
Q2 2024

Aug 12, 2024
SELL
$3.04 - $4.23 $114,875 - $159,843
-37,788 Reduced 7.49%
466,581 $1.89 Million
Q1 2024

May 08, 2024
BUY
$2.88 - $4.89 $101,361 - $172,103
35,195 Added 7.5%
504,369 $1.74 Million
Q4 2023

Feb 06, 2024
SELL
$1.08 - $3.63 $23,537 - $79,112
-21,794 Reduced 4.44%
469,174 $1.53 Million
Q3 2023

Nov 08, 2023
BUY
$2.81 - $5.69 $69,938 - $141,618
24,889 Added 5.34%
490,968 $1.43 Million
Q2 2023

Aug 09, 2023
BUY
$4.45 - $7.57 $577,601 - $982,570
129,798 Added 38.6%
466,079 $2.54 Million
Q1 2023

May 11, 2023
BUY
$2.48 - $5.22 $59,202 - $124,611
23,872 Added 7.64%
336,281 $1.56 Million
Q4 2022

Feb 13, 2023
BUY
$1.75 - $3.96 $7,297 - $16,513
4,170 Added 1.35%
312,409 $706,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $7.46 $84,582 - $204,202
27,373 Added 9.75%
308,239 $971,000
Q2 2022

Aug 15, 2022
SELL
$1.92 - $6.28 $337,969 - $1.11 Million
-176,026 Reduced 38.53%
280,866 $773,000
Q1 2022

May 13, 2022
BUY
$5.07 - $7.2 $104,056 - $147,772
20,524 Added 4.7%
456,892 $2.75 Million
Q4 2021

Feb 11, 2022
BUY
$5.67 - $8.54 $36,174 - $54,485
6,380 Added 1.48%
436,368 $2.81 Million
Q3 2021

Nov 16, 2021
BUY
$13.4 - $16.3 $54,095 - $65,803
4,037 Added 0.95%
429,988 $5.93 Million
Q2 2021

Aug 16, 2021
BUY
$14.81 - $19.13 $138,118 - $178,406
9,326 Added 2.24%
425,951 $6.32 Million
Q1 2021

May 17, 2021
BUY
$14.52 - $23.53 $191,664 - $310,596
13,200 Added 3.27%
416,625 $7.42 Million
Q4 2020

Feb 16, 2021
BUY
$10.14 - $15.19 $65,433 - $98,021
6,453 Added 1.63%
403,425 $5.76 Million
Q3 2020

Nov 13, 2020
BUY
$9.57 - $21.32 $507,152 - $1.13 Million
52,994 Added 15.41%
396,972 $4.01 Million
Q2 2020

Aug 14, 2020
BUY
$12.21 - $16.99 $316,727 - $440,720
25,940 Added 8.16%
343,978 $5.06 Million
Q1 2020

May 15, 2020
BUY
$9.03 - $19.72 $117,489 - $256,576
13,011 Added 4.27%
318,038 $4.25 Million
Q4 2019

Feb 07, 2020
BUY
$13.01 - $17.15 $347,692 - $458,333
26,725 Added 9.6%
305,027 $4.3 Million
Q3 2019

Nov 08, 2019
BUY
$14.55 - $20.56 $139,432 - $197,026
9,583 Added 3.57%
278,302 $4.55 Million
Q2 2019

Aug 09, 2019
BUY
$15.0 - $19.62 $55,875 - $73,084
3,725 Added 1.41%
268,719 $4.22 Million
Q1 2019

May 14, 2019
BUY
$11.65 - $17.72 $157,321 - $239,290
13,504 Added 5.37%
264,994 $4.6 Million
Q4 2018

Feb 14, 2019
SELL
$10.72 - $16.73 $8,350 - $13,032
-779 Reduced 0.31%
251,490 $2.8 Million
Q3 2018

Nov 13, 2018
BUY
$17.73 - $26.69 $220,578 - $332,050
12,441 Added 5.19%
252,269 $6.16 Million
Q2 2018

Aug 08, 2018
BUY
$10.79 - $24.44 $185,048 - $419,146
17,150 Added 7.7%
239,828 $4.35 Million
Q1 2018

May 07, 2018
BUY
$9.0 - $20.16 $61,200 - $137,088
6,800 Added 3.15%
222,678 $2.49 Million
Q4 2017

Jan 17, 2018
SELL
$13.26 - $22.86 $25,538 - $44,028
-1,926 Reduced 0.88%
215,878 $4.2 Million
Q3 2017

Nov 13, 2017
BUY
$19.76 - $24.9 $4.3 Million - $5.42 Million
217,804
217,804 $4.71 Million

Others Institutions Holding OMER

# of Institutions
124
Shares Held
25.2M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $541M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email